Background Diabetes, a chronic disease worldwide, may be associated with a poorer
prognosis in patients with coronavirus disease 2019 (COVID-19). While some …

Aim To investigate the impact of the COVID-19-pandemic on antidiabetic drug initiation
Methods Using Swedish national health registers, an interrupted time series study for all first …

Objective To investigate the methodological quality of published systematic reviews of
factors associated with COVID-19 in people with diabetes. Method Systematic review with …

Aims To analyse if antidiabetic treatment was associated with better COVID-19 outcomes in
type 2 diabetic patients, measured by hospital admission and mortality rates as severe …

Background Due to the worldwide spread of COVID-19, various countries have designed
scientific studies on different aspects of the disease. Patients with diabetes mellitus (DM) …

Objective This study aimed to assess the effects of sodium-glucose co-transporter inhibitors
(SGLT2i), glucagon-like peptide-1 receptor agonists (GLP-1RA), and dipeptidyl peptidase-4 …

Antiviral treatment for SARS-CoV2 (Severe Acute Respiratory Syndrome Coronavirus-2) is
still being studied for its effectivity. The antivirals in the July 3, 2021 edition of the COVID-19 …

Background: COVID-19 patients experience dynamic changes in immune and cellular
function over time with potential clinical implications. However, there is insufficient research …

COVID‐19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐
CoV‐2), has led to enormous morbidity and mortality worldwide. After gaining entry into the …

Diabetes mellitus (DM) is an independent risk factor for admission to intensive care unit and
death in patients with coronavirus disease 2019 (COVID-19). On the other hand …